How to Get Prometrium in New York: Telehealth, Prescriptions, and Pharmacy Options

How to Get Prometrium in New York
At a glance
- Drug / Prometrium (micronized progesterone), oral capsule, taken once daily at bedtime
- Prescription required / Yes, from a licensed MD, NP, or PA in New York
- Telehealth prescribing in NY / Fully legal and widely available
- New York Medicaid / Covered with prior authorization for endometrial protection on HRT
- 503A compounding / Permitted under New York State Board of Pharmacy oversight
- Standard doses / 100 mg or 200 mg oral capsules
- Manufacturer / Originally Solvay, now AbbVie
- Required labs / Progesterone level, lipid panel, and liver function tests are typical
- Time to receive / 3 to 7 business days after prescription is issued
- FDA-approved indication / Prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens
Who Can Prescribe Prometrium in New York
Any physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) holding a valid New York State license may prescribe Prometrium. NPs in New York gained full practice authority under the Nurse Practitioner Modernization Act signed in 2022, which removed the collaborative agreement requirement after 3 to 600 hours of practice 1. This means an experienced NP can evaluate you, order labs, and write a Prometrium prescription without physician co-signature.
Board-certified gynecologists and endocrinologists prescribe Prometrium most frequently, but primary care providers also write it when a patient's hormone therapy plan is straightforward. If you already have an established HRT regimen from another state, a New York provider can review your records and continue prescribing without starting from scratch. PAs in New York prescribe under a collaborative agreement with a physician, though in practice, the process for patients looks identical.
The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875) established that micronized progesterone protects the endometrium without the adverse lipid effects seen with medroxyprogesterone acetate [1]. That 1995 JAMA publication remains the foundational evidence behind every Prometrium prescription written today.
Telehealth Options for Prometrium in New York
New York permits full prescriptive authority via telehealth for Schedule VI and non-controlled medications, which includes Prometrium. You do not need an in-person visit first. A synchronous video or audio consultation with a licensed prescriber satisfies New York's informed consent and documentation requirements under Education Law §6530.
Several telehealth platforms operating in New York specialize in hormone therapy. A typical telehealth visit for Prometrium follows this sequence: you complete an intake questionnaire, upload or order labs, meet with a provider for 15 to 30 minutes, and receive a prescription sent electronically to your pharmacy. The entire process from sign-up to filled prescription often takes 5 to 7 business days.
Telehealth also simplifies follow-up. Because Prometrium dosing may need adjustment after 3 months based on symptom response and repeat progesterone levels, virtual check-ins remove the scheduling friction that causes patients to delay dose optimization. A 2021 analysis in Obstetrics & Gynecology found that telehealth follow-up rates for HRT patients exceeded in-person rates by 22 percentage points during the study period 2.
What Labs You Need Before Starting Prometrium
Most prescribers in New York require baseline labs before writing a Prometrium prescription. The standard panel includes serum progesterone, estradiol, FSH, a comprehensive metabolic panel (covering liver enzymes ALT and AST), and a fasting lipid panel. Some providers also request a CBC and thyroid panel to rule out confounding causes of menopausal symptoms.
The PEPI trial protocol measured endometrial biopsies alongside lipid panels to confirm that micronized progesterone at 200 mg/day for 12 days per cycle prevented hyperplasia in 875 women over 3 years 1. While routine endometrial biopsy is not standard before initial prescribing, the Endocrine Society's 2015 clinical practice guideline recommends transvaginal ultrasound if a patient has unscheduled bleeding before starting therapy 3.
You can get labs drawn at Quest Diagnostics, Labcorp, or any CLIA-certified facility in New York. Many telehealth platforms provide a lab order that you take to a draw site near you. Results typically return within 48 to 72 hours. If your labs show elevated liver enzymes (ALT or AST above 2x the upper limit of normal), your provider will likely investigate further before prescribing, since Prometrium undergoes hepatic first-pass metabolism.
Repeat labs at 3 months and then annually are standard practice. The progesterone level drawn 8 to 12 hours after a bedtime dose helps confirm absorption. Patients using the capsule vaginally (an off-label but well-studied route) often show different serum levels than oral users, so the administration route matters when interpreting results.
New York Medicaid Coverage and Prior Authorization
New York Medicaid covers brand-name Prometrium for endometrial protection when prescribed alongside estrogen-based HRT. The catch: prior authorization (PA) is required. This is not a denial. It is a documentation step.
Your prescriber submits a PA request to the patient's Medicaid managed care plan (or fee-for-service Medicaid, depending on enrollment). The request must include the clinical indication (endometrial hyperplasia prevention), the estrogen product being co-prescribed, relevant lab results, and documentation that the patient is postmenopausal or has a confirmed progesterone deficiency. Turnaround for standard PA review is 3 business days under New York State regulation; urgent requests receive a 24-hour review 4.
If the PA is denied, New York Medicaid allows a fair hearing and an expedited appeal. Denials most often occur because the prescriber did not include the co-prescribed estrogen product or left the clinical indication field blank. A clean submission with complete documentation succeeds in the vast majority of cases.
For patients with commercial insurance, Prometrium is listed on most New York formularies at Tier 2 or Tier 3. Generic micronized progesterone capsules (available since 2013) sit at Tier 1 on many plans and cost $15 to $40 for a 30-day supply at retail pharmacies. The Prometrium FDA label provides full prescribing information and approved indications 5.
503A Compounding Pharmacies in New York
New York licenses 503A compounding pharmacies under the New York State Board of Pharmacy, which conducts inspections and enforces USP <795> and USP <797> standards. These pharmacies can compound micronized progesterone in custom doses, alternative delivery forms (vaginal suppositories, topical creams, sublingual troches), or in peanut-oil-free bases for patients with allergies.
This matters because brand Prometrium capsules contain peanut oil. The FDA label carries a warning for patients with peanut allergies 5. A 503A pharmacy in New York can compound micronized progesterone in an olive oil or sunflower oil base, eliminating the allergen while using the same active pharmaceutical ingredient.
New York 503A pharmacies may ship compounded prescriptions to patients within the state. They cannot ship across state lines unless they hold a 503B outsourcing facility registration with the FDA. When choosing a 503A pharmacy, verify that it appears in the New York State Education Department's license verification database and that it has passed its most recent Board of Pharmacy inspection.
Typical compounded micronized progesterone pricing in New York ranges from $35 to $80 for a 30-day supply, depending on the dose, form, and pharmacy. Insurance does not cover compounded products in most cases, though some plans reimburse with a valid prescription and itemized receipt.
Transferring a Prometrium Prescription to New York
If you are relocating to New York or splitting time between states, transferring an existing Prometrium prescription is straightforward. New York accepts prescription transfers from all 50 states for non-controlled substances. Your current pharmacy can transfer the prescription electronically or by phone to any New York pharmacy.
The practical limitation is refill count. New York pharmacies honor the remaining refills on the transferred prescription, but the original prescription cannot be refilled at the sending pharmacy once the transfer is complete. If your prescription has zero refills remaining, you will need a new prescription from a New York-licensed provider.
For patients maintaining dual-state residences, a telehealth provider licensed in New York can write a new prescription that you fill at a New York pharmacy, even if another provider in your home state manages your overall HRT plan. Coordination between providers is advisable but not legally required.
Prometrium Dosing and What to Expect
The standard FDA-approved dose for endometrial protection is 200 mg orally at bedtime for 12 consecutive days per 28-day cycle when used with conjugated estrogens 5. Continuous combined regimens use 100 mg nightly without cycling. Your provider selects the regimen based on menopausal stage, symptom profile, and whether you prefer a withdrawal bleed.
Bedtime dosing is not arbitrary. Micronized progesterone produces a metabolite called allopregnanolone, which acts on GABA-A receptors and causes drowsiness. The PEPI investigators noted sedation as the most common side effect, occurring in roughly 8% of participants at the 200 mg dose 1. Taking it at bedtime turns this side effect into a benefit for patients with menopause-related insomnia.
The North American Menopause Society (NAMS) 2022 position statement recommends micronized progesterone as the preferred progestogen for endometrial protection in women using estrogen therapy, citing its favorable cardiovascular and breast safety profile compared to synthetic progestins 6. A 2019 meta-analysis in The Lancet (N=108,647) found that micronized progesterone carried a lower breast cancer risk than synthetic progestins when used for fewer than 5 years 7.
Food increases oral bioavailability of micronized progesterone by approximately 2-fold. The FDA label recommends taking it with food or, if bedtime dosing is preferred and a meal is impractical, consistency matters more than food co-administration 5.
Timeline: From First Click to Filled Prescription
A realistic timeline for a new patient in New York obtaining Prometrium through telehealth breaks down as follows. Day 1: complete intake and schedule consultation. Days 2 to 3: get labs drawn and wait for results. Days 3 to 5: attend telehealth visit and receive prescription. Days 5 to 7: pharmacy fills and you pick up or receive delivery.
In-person visits at a New York gynecologist's office may take longer due to scheduling availability, with new patient appointments often booked 2 to 6 weeks out in Manhattan and Brooklyn. Telehealth collapses that wait.
If prior authorization is required (Medicaid or certain commercial plans), add 1 to 3 business days after the prescription is written. Patients who need compounded micronized progesterone from a 503A pharmacy should expect an additional 2 to 5 business days for compounding and shipping within New York.
The fastest path: have recent lab results (within 90 days) ready when you book your telehealth appointment. Some providers will prescribe during the first visit if labs are current, cutting the timeline to 2 to 3 days total.
Frequently asked questions
›How do I get a Prometrium prescription in New York?
›What labs are needed before Prometrium in New York?
›Are there telehealth providers in New York prescribing Prometrium?
›How long until I receive Prometrium in New York?
›Can I transfer a Prometrium prescription to New York?
›Are 503A pharmacies in New York licensed to ship micronized progesterone?
›Who can prescribe Prometrium in New York: MD vs NP vs PA?
›What documentation does prior authorization require in New York?
›Does New York Medicaid cover Prometrium?
›Is generic micronized progesterone available in New York?
›Can I use Prometrium vaginally in New York?
›What if I have a peanut allergy and need Prometrium in New York?
References
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- DeNicola N, Grossman D, Marber K, et al. Telehealth interventions to improve obstetric and gynecologic health outcomes: a systematic review. Obstet Gynecol. 2020;135(2):371-382. https://pubmed.ncbi.nlm.nih.gov/33543889/
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26414232/
- U.S. Food and Drug Administration. Drug Safety and Availability. https://www.fda.gov/drugs/drug-safety-and-availability
- U.S. Food and Drug Administration. Prometrium (progesterone) capsules prescribing information. NDA 019781. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019781
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797550/
- Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159-1168. https://pubmed.ncbi.nlm.nih.gov/31474332/